ARTA
FOLD

A.R.T. Advisors’s Amicus Therapeutics FOLD Stock Holding History

A.R.T. Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-40,147
Closed -$322K – 1459
2019
Q3 		$322K Buy
+40,147
New +$436K 0.02% 1021
2019
Q2 		– Sell
-99,706
Closed -$1.36M – 1449
2019
Q1 		$1.36M Buy
+99,706
New +$1.22M 0.08% 369
2018
Q4 		– Sell
-174,871
Closed -$2.11M – 1416
2018
Q3 		$2.11M Buy
+174,871
New +$2.45M 0.1% 277
2018
Q1 		– Sell
-44,000
Closed -$633K – 1586
2017
Q4 		$633K Sell
44,000
-16,900
-28% -$232K 0.03% 797
2017
Q3 		$918K Sell
60,900
-127,200
-68% -$1.68M 0.05% 576
2017
Q2 		$1.89M Buy
188,100
+136,900
+267% +$1.1M 0.1% 292
2017
Q1 		$365K Buy
+51,200
New +$324K 0.02% 920
2016
Q1 		– Sell
-511,384
Closed -$4.96M – 1461
2015
Q4 		$4.96M Buy
+511,384
New +$4.61M 0.24% 85
2015
Q2 		– Sell
-177,312
Closed -$1.93M – 1550
2015
Q1 		$1.93M Sell
177,312
-119,612
-40% -$1.05M 0.07% 404
2014
Q4 		$2.47M Buy
+296,924
New +$2.04M 0.09% 312

Other funds holding FOLD

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

A.R.T. Advisors's FOLD Position: Q4 2019 in Review

A.R.T. Advisors sold out of Amicus Therapeutics (FOLD) in Q4 2019, closing a stake of 40,147 shares — an estimated $322K sold.

A.R.T. Advisors first reported a position in FOLD in Q4 2014 and held it in 10 quarters. The position peaked at $4.96M in Q4 2015. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2019.

  • A.R.T. Advisors reported no remaining Amicus Therapeutics position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 40,147 Amicus Therapeutics shares in Q4 2019, an estimated $322K.
  • A.R.T. Advisors first reported a position in Amicus Therapeutics in Q4 2014 and held it in 10 quarters.
  • A.R.T. Advisors's Amicus Therapeutics position peaked at $4.96M in Q4 2015.
  • 224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.